Our team is engaged in interdisciplinary studies focused on creating innovative materials and approaches for combating infectious diseases. We utilize bio-derived substances, repurposed agents, and nanotechnology-based materials in our research, which encompasses various related subjects:

• Bacterial small noncoding RNAs (sRNAs): Functions and mechanism of action (MOA) 

• Outermembrane vesicles (OMVs): Understanding biogenesis pathways and their genetic components using multiomics studies and their utilization in the development of novel vaccine and antibacteral platforms

• Nanoantibiotics: Development of new metal oxides/black phosphorus-based nanoantibiotic platforms and stimuli-responsive biomimmetic nanoantibiotics 

• Synergistic antibiotics: Identification of novel synergistic materials to antibiotics and their mechanism of action

• Gene expression regulation by ribonucleases and their inhibitors: New discovery of cellular regulators of ribonucleases and their mechanisms

• Drug-delivery vehicle: New development of drug-delivery vehicles for biomedical applications